EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Polygenic Prediction of Recurrent Events After Early-Onset Myocardial Infarction

Maddalena Ardissino iD, Elvezia Maria Paraboschi, Samuel A Lambert iD, Lois G Kim iD, Martin Kelemen iD, Giuseppe Maglietta iD, Antonio Crocamo, Giulia Magnani, Serena Bricoli iD, Luigi Vignali, Giampaolo Niccoli, Marco Tubaro iD und 12 weitere

Circulation: Genomic and Precision Medicine · 2024

DOI: 10.1161/circgen.124.004687 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation: Genomic and Precision Medicine, 2024. Verfasst von Maddalena Ardissino und 23 weiteren Autor:innen. Beteiligte Einrichtung: British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care (M.A.,S.A.L., L.G.K., M.K., M.I., E.D.A., A.S…. Hauptthemen laut MEDLINE: Myocardial Infarction, Recurrence, Multifactorial Inheritance. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, British Heart Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Myocardial infarction (MI) is a complex disease caused by both lifestyle and genetic factors. This study aims to investigate the predictive value of genetic risk, in addition to traditional cardiovascular risk factors, for recurrent events following early-onset MI. METHODS: The Italian Genetic Study of Early-Onset Myocardial Infarction is a cohort study enrolling patients with MI before 45 years. Monogenic variants causing familial hypercholesterolemia were identified, and a coronary artery disease polygenic score (PGS) was calculated. Ten-fold cross-validated Cox proportional hazards models were fitted sequentially including all clinical variables, the PGS, and monogenic variants on the composite outcome of cardiovascular death, recurrent MI, stroke, or revascularization. RESULTS: During a 19.9-year follow-up, 847 (50.7%) patients experienced recurrent events. Each 1-SD higher PGS was associated with a 21% higher hazard of recurrent events (hazard ratio, 1.21 [95% CI, 1.13–1.31]; P =4.04×10 −6 ). Except for secondary prevention, PGS was the strongest determinant of recurrent event risk (C index, 0.56 [95% CI, 0.54–0.58]) compared with clinical risk factors. Overall, predictive performance of clinical risk factors (C index, 0.69 [95% CI, 0.67–0.71]) improved after adding the PGS (C index, 0.69 [95% CI, 0.68–0.71]; P =0.006). When dividing the population by PGS quintiles, the highest fifth had a 57% higher hazard of recurrent events than the lowest fifth (hazard ratio, 1.57 [95% CI, 1.26–1.96]; P =5.57×10 −5 ). CONCLUSIONS: When compared with other clinical risk factors, PGS was the strongest predictor of event recurrence among patients with an early-onset MI. Though the discriminative power of recurrent event prediction in this cohort was modest, the addition of PGS significantly improved discrimination.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial InfarctionRecurrenceMultifactorial InheritanceHumansMaleFemaleAdultMiddle AgedRisk FactorsAge of OnsetProportional Hazards ModelsCohort StudiesHyperlipoproteinemia Type IIFollow-Up StudiesGenetic Predisposition to DiseaseCoronary Artery Disease

Stichwörter der Autor:innen

cardiovascular diseasescoronary artery diseasegenetic risk scoregeneticsheart disease risk factors

Autor:innen und Institutionen

  • British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care (M.A.,S.A.L., L.G.K., M.K., M.I., E.D.A., A.S.B.).
  • Victor Phillip Dahdaleh Heart and Lung Research Institute (M.A.,S.A.L., L.G.K., M.K., M.I., E.D.A., A.S.B.).
  • National Heart and Lung Research Institute (M.A.,L.P., A.S., F.S.N.).
  • Medical Research Council-London Institute of Medical Sciences, Imperial College London, United Kingdom (M.A.,A.M.).
  • Department of Biomedical Sciences, Humanitas University (E.M.P., R.A.).
  • IRCCS Humanitas Research Hospital, Milan, Italy (E.M.P., R.A.).

ORCID-Profile: Maddalena Ardissino, Samuel A Lambert, Lois G Kim, Martin Kelemen, Giuseppe Maglietta, Serena Bricoli, Marco Tubaro, Arunashis Sau, Fu Siong Ng, Antonio de Marvao, Michael C Honigberg, Pradeep Natarajan, Adam J Nelson, Michael Inouye, Emanuele Di Angelantonio, Rosanna Asselta, Diego Ardissino, Adam S Butterworth

Förderung

  • NHLBI NIH HHS
  • British Heart Foundation

Zitieren

APA

Ardissino, M., Paraboschi, E. M., Lambert, S. A., Kim, L. G., Kelemen, M., Maglietta, G., Crocamo, A., Magnani, G., Bricoli, S., Vignali, L., Niccoli, G., Tubaro, M., Pastika, L., Sau, A., Ng, F. S., de Marvao, A., Honigberg, M. C., Natarajan, P., Nelson, A. J., …, & Butterworth, A. S. (2024). Polygenic Prediction of Recurrent Events After Early-Onset Myocardial Infarction. Circulation: Genomic and Precision Medicine. https://doi.org/10.1161/circgen.124.004687

Vancouver

Ardissino M, Paraboschi EM, Lambert SA, Kim LG, Kelemen M, Maglietta G, et al. Polygenic Prediction of Recurrent Events After Early-Onset Myocardial Infarction. Circulation: Genomic and Precision Medicine. 2024. doi:10.1161/circgen.124.004687

BibTeX
@article{Ardissino2024,
  author = {Ardissino, Maddalena and Paraboschi, Elvezia Maria and Lambert, Samuel A and Kim, Lois G and Kelemen, Martin and Maglietta, Giuseppe and Crocamo, Antonio and Magnani, Giulia and Bricoli, Serena and Vignali, Luigi and Niccoli, Giampaolo and Tubaro, Marco and Pastika, Libor and Sau, Arunashis and Ng, Fu Siong and de Marvao, Antonio and Honigberg, Michael C and Natarajan, Pradeep and Nelson, Adam J and Inouye, Michael and Di Angelantonio, Emanuele and Asselta, Rosanna and Ardissino, Diego and Butterworth, Adam S},
  title = {Polygenic Prediction of Recurrent Events After Early-Onset Myocardial Infarction},
  journal = {Circulation: Genomic and Precision Medicine},
  year = {2024},
  doi = {10.1161/circgen.124.004687}
}
Kostenlos starten →